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1. Introduction 
In a previous note [ 11 we described an esterase Es, 
specific for fetal brain from strain A mouse. This en- 
zyme has been shown to be an arylesterase (EC. 3.1 .1.2.) 
which is not inhibited by 1Cr4 M eserine. It is present 
in the brain of fetuses from the sixteenth day of gesta- 
tion until 2 days after birth and is absent in adult 
mouse brain. As this enzyme seemed to be a marker 
of nervous tissue differentiation we have tried to dem- 
onstrate its presence in neuronal tumors. Previous at- 
tempts to identify this esterase in neuroblastoma 
C 1300, transplanted on strain A mouse, were unsuc- 
cessful. 
We report here some preliminary results on the 
search for esterase Es on experimentally transplanted 
teratocarcinomas. 
2. Materials 
2.1. The following experimental teratomas were pro- 
vided by Dr. L.C. Stevens (Jackson lab., Bar Harbour): 
i) OTT 55.68 was obtained in 1966 by grafting a 3 
days 129/SV embryo into the testis of an adult 129 
mouse. 
ii) OTT 60.50 was obtained in 1967 by grafting a 
6 days 129/SV embryo into an adult 129 mouse testis. 
These tumors were transplanted subcutaneously 
and differentiated in a variety of tissues (i.e. neural, 
epithelial, muscle) [2]. 
iii) OTT 24.66 was obtained in 1968 by grafting a 
6 days A/HE embryo into the testis of an Fr 129XA/’ 
He male. 
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The tumor OTT 24.66, also transplanted subcuta- 
neously, differentiates mainly in anaplastic nervous 
tissue. Embryoid bodies which are known to be the 
equivalent of a primitive mbryo with its 3 germ layers 
are not present in this tumor. All these tumors are 
transplanted every 3 or 4 weeks. The tumors are re- 
moved from the mice after a cervical dislocation, 
washed twice in physiological buffer and pooled at 
-20°C until used. 
2.2. 7,10, I3 day-old embryos 
Mice were allowed to mate overnight and were 
checked for sperm plugs the next morning. The day 
on which the sperm plugs are detected is designated 
as day no. 2. The embryos were carefully removed 
from the uterus to prevent any contamination by the 
gestation tissues, washed in (PBS), pooled for extrac- 
tion and stored at -20°C. 
2.3. 18 day-oh.2 embryo, newborn brains were obtain- 
ed as previous-described [l].
3. Methods 
3.1. Extraction 
After thawing, tumors as well as fetal and newborn 
brains were minced, suspended in 4 vol of cold 50 mM 
P04HK buffer, pH 7.5, disrupted by 6 strokes in a 
Dounce homogenizer. Triton X-100 (OS%, W/V) was 
added to facilitate the release of the esterase Es which 
mainly exists in a membrane bound form. 
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Solubilisation was then accomplished by ultrasonic 
treatment at 4°C in a M.S.E. ultrasonic disintegrator 
(5 pulses of 30 set each at 30 set intervals). The homo- 
genate was centrifugated at 100,000 g for 1 hr, in a 
Spinco model L or in a Sorvall centrifuge at 40,000 g 
for 30 min. 
The supernatant was dialysed overnight against 50 
mM P04HK buffer, pH 7.5, without Triton X-100, at 
4°C and stored at -80°C in small aliquots. 
Alternatively and to avoid any contamination by 
physiological fluids some experiments were carried 
out with dissociated cells, prepared according to the 
technique of Howard et al. [3]. Fresh samples of tis- 
sue were incubated with gentle stirring for 30 min at 
37°C in 5 vol of Difco 199 medium pH 7.5, contain- 
ing: 0.10% collagenase, 0.20% hyaluronidase (both 
Sigma type l), 0.40 M, 0.01% sodium citrate, and 
2 X 1tJ3 M fl-mercaptoethanol. 
The dissociated cells were collected after 5 min 
centrifugation at 150 g and washed twice in Difco 
199 medium. The cells were homogenised as de- 
scribed above. 
3.2. Ammonium sulfate precipitation 
The supernatant from the centrifugation at 40,000 
g was precipitated at 4°C by ammonium sulfate, 0.55 
M. The precipitate was gently suspended in 2 ml of 
buffer and extensively dialysed against 50 mM PO,+HK 
buffer, pH 7.5. 
3.3. Electrophoresis separation and identification of 
esterase E3 with P-naphthyl acetate have been carried 
out as previously described [ 11. 
3.4. Preparations of neuronal and glial fractions 
An attempt has been made to determine the origin 
of the cells containing the E3 activity. Neuronal and 
glial enriched fractions from tumor tissue and fetal 
brain tissue were prepared according to the technique 
of Packman et al. [4]. 
4. Results and discussion 
As shown in fig. 1, esterase E3 can be demonstrated 
in electrophoresed extracts of both 18 day fetal brain 
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Fig. 1. Electrophoretic patterns of carboxylic esterase in solu- 
ble extracts of fetal brain (18 days of gestation) (F), terato- 
carcinoma OTT 24.66 (T) and adult brain (A). Each reservoir 
contains 100 ~1 of soluble extracts (10 mg/ml). Electrophore- 
sis was carried out in 5% acrylamide -0.8% agarose gels mixed 
in 25 mM barbital buffer, pH 8.2. Electrophoresis was run for 
3 hr at 6 V/cm in a cold room (+ 4°C). The slabs were incu- 
bated for 45 min in a solution of phosphate buffer, 50 mM, 
pH 7.5, containing 10 mmol of p naphthyl acetate and 5 mg/ 
10 ml of diazotized orthodianisidine (Diazoblue B) [S]. 
and OTT 24.66. The esterase Ea is present in embry- 
onic brain at 16 days and cannot be detected until 48 
hr after birth. The esterase band no. 5 is a serum con- 
taminant. The esterase Es is already present in tera- 
toma OTT 24.66 as soon as the tumor can be removed 
from the mouse (10 to 12 days after transplantation). 
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Fig. 2. Comparative lectrophoretic patterns of carboxylic esterases of: 1) 7 &y-old embryo (whole embryo); 2) brain fetal extract 
(18 days); 3) OTT 24.66 teratocarcinoma; 4) OTT 60.50 teratocarcinoma; 5) OTT 55.68 teratocarcinoma. In each starting reservoir 
there is the same amount of proteins (10 to 11 mg/ml). 
Fig. 2 shows the absence of esterase Es in extracts 
from embryos less than 16 days, from teratoms OTT 
60.50, and from OTT 55.68. 
Esterase could not be demonstrated in soluble ex- 
tracts of liver, kidney and muscle from 18 day-old 
fetuses. 
The possibility of contamination of brain extracts 
by the mid-gestation tissue derived from both mater- 
nal and fetal origin was then considered. In the first 
half of pregnancy some esterases can be revealed in 
the trophoblast tissue (foetal placenta), in the deci- 
dua (maternal placenta), and in the yolk sac (visceral 
endoderm) [6,7]. Sherman showed that a pool of A 
and B isozymes with esterase activity was common to 
the embryo proper, while an esterase F activity was 
present in trophoblast preparations as early in gesta- 
tion as the eight day, at least. The esterase F was never 
detected in the amnion or fetus at any stage of gesta- 
tion. 
However, we have never detected esterase Es in the 
soluble fractions of homogenates obtained from ex- 
tracts of maternal uterus and derived tissue, nor in 
fetal envelopes, at different times of gestation. 
Attempts to study the quantitative differences in 
esterase activity in soluble extracts were unsuccessful. 
This was due to the high background produced by non- 
specific serum esterases which contaminated the extract. 
The specific activity expressed as pmol of /3 naphthyl 
acetate hydrolysed per mm per mg of protein varied in 
the range of 6.50 to 9 pmol in tumors as well as in fetal 
brain and serum. 
Preliminary results on the cell localization of esterase 
Es by electrophoresis how that the enzyme is mainly 
present in the glial fraction of both fetal brain and tera- 
tocarcinoma. 
The most important feature of this preliminary work 
is the demonstration of an esterase of fetal origin in 
some teratocarcinomas. 
The exact significance of esterase Es is still unknown 
but if we assume that esterase Es is a transitory mar- 
ker of neural differentiation, its appearance in terato- 
carcinoma OTT 24.66 could be explained by the pres- 
ence of nervous cells passing through this stage of dif- 
ferentiation at the time of removal. This may be true 
even if this tumor, although normally predominantly 
neural, also contained epithelial and mesodermic tis- 
sue and large numbers of undifferentiated stem cells. 
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